Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Morice (Cottingham, United Kingdom), A. Loonat (Cottingham, United Kingdom), C. Wright (Cottingham, United Kingdom). The effect of Octreotide in patients with refractory Chronic Cough. 1287

Member's Comments

No comment yet.

Related content which might interest you: Chronic refractory cough Source: Virtual Congress 2020 – Clinical grand round: revisiting current guidelines Year: 2020 The Efficacy of Bradanicline in Refractory Chronic Cough Source: Virtual Congress 2020 – Chronic cough: only symptom or disease? Year: 2020 Chronic cough diagnosis and treatment Source: International Congress 2017 – ME4 Chronic cough - FULLY BOOKED Year: 2017 Chronic inhaled corticosteroids in patients with bronchiectasis who suffer an exacerbation Source: International Congress 2016 – Possible phenotypes of bronchiectasis and exacerbations Year: 2016 Response of chronic cough to acid suppresive therapy in patients with gastroesophageal reflux disease Source: Annual Congress 2013 –New treatments and old dilemmas in the clinical management of lung diseases Year: 2013 Response to subcutaneous octreotide in a cohort of patients with bronchorrhoea Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis Year: 2015 Successful Management of Chronic Cough Source: ERS Live 2007 Year: 2007 Chronic cough Source: Breathe 2014; 10:349-352 Year: 2014 Treatment of chronic cough with morphine Source: Eur Respir J 2006; 28: Suppl. 50, 437s Year: 2006 Capsaicin sensitivity in patients with chronic refractory unexplained cough Source: Annual Congress 2011 - The new clinical spectrum of lung diseases: from bronchi to pleura Year: 2011 Medication Effect on Acute Exacerbation and Mortality in Patients with Coexistent COPD and GERD Source: International Congress 2018 – COPD and extrapulmonary comorbidities Year: 2018 Symptoms of autonomic dysfunction in chronic cough patients Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases Year: 2016 Management of refractory dyspnoea in COPD Source: Virtual Congress 2021 – Highlights from the JAMA Network on idiopathic pulmonary fibrosis, chronic obstructive pulmonary disease and lung cancer screening Year: 2021 Microbiome Use to Stratify Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease (MUSIC) trial: baseline data and impact of inhaled corticosteroid withdrawal in severe COPD with frequent exacerbations Source: Virtual Congress 2020 – COPD : inhaled corticosteroids, bronchodilators and eosinophils Year: 2020 Evaluation of nasal optiflow device in management of COPD patients in acute exacerbations Source: International Congress 2015 – Acute critical care: COPD, muscles and weaning Year: 2015 Efficacy and response predictors of inhaled corticosteroid treatment on chronic cough Source: International Congress 2016 – Managing multimorbidity and lifestyle change in primary care Year: 2016 Opioids for chronic refractory breathlessness: patient predictors of beneficial response Source: Eur Respir J 2013; 42: 758-766 Year: 2013 Opiate therapy in chronic cough Source: Eur Respir J 2005; 26: Suppl. 49, 129s Year: 2005 Chronic cough in COPD Source: Annual Congress 2003 - New pathophysiological aspects in COPD Year: 2003